Baseline Modified Glasgow Prognostic Score Associated with Survival in Metastatic Urothelial Carcinoma Treated with Immune Checkpoint Inhibitors

BACKGROUND: The modified Glasgow prognostic score (mGPS), a clinical tool that incorporates albumin and C‐reactive protein, has proven useful in the prognostication of multiple cancers. Several immune checkpoint inhibitors (ICIs) have been approved for the treatment of metastatic urothelial cell car...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Oncologist
Main Authors: Brown, Jacqueline T., Liu, Yuan, Shabto, Julie M., Martini, Dylan J., Ravindranathan, Deepak, Hitron, Emilie Elise, Russler, Greta Anne, Caulfield, Sarah, Yantorni, Lauren Beth, Joshi, Shreyas S., Kissick, Haydn, Ogan, Kenneth, Harris, Wayne B., Carthon, Bradley C., Kucuk, Omer, Master, Viraj A., Bilen, Mehmet Asim
Formato: Artigo
Idioma:Inglês
Publicado: John Wiley & Sons, Inc. 2021
Assuntos:
Genitourinary Cancer
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8100543/
https://ncbi.nlm.nih.gov/pubmed/33634507
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/onco.13727
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares